1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow Antithrombin III Deficiency: new trials by email Literature Review of Antithrombin III Deficiency trials Research Report on Antithrombin III Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atenativ Effect on Uterine Blood Flow and Preeclampsia Atenativ - Antithrombin III Deficiency | Phase 4 | Withdrawn | Vastra Gotaland Region | 2016-01-01 | 2017-09-26 |
Pre-Eclampsia (1)
Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Blood Protein Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hypertension, Pregnancy-Induced (1) · Pregnancy Complications (1) · Thrombophilia (1) · Urogenital Diseases (1)
Antithrombin III (1)
Sweden (1)
Margareta Hellgren, MD,PhD,prof (1)
PMID 11057854, PMID 14719181, PMID 15500369, PMID 17636190, PMID 18226126, PMID 2329037, PMID 6484893, PMID 6618278, PMID 6872275